Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer

PURPOSE: Breast cancer has become a major public health threat in the current society. Anthracycline doxorubicin (DOX) is a widely used drug in breast cancer chemotherapy. We aimed to investigate the immunogenic death of breast tumor cells caused by DOX, and detect the effects of combination of DOX...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jian, Deng, Fusheng, Jia, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597411/
https://www.ncbi.nlm.nih.gov/pubmed/31281723
http://dx.doi.org/10.4048/jbc.2019.22.e23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597411/
https://www.ncbi.nlm.nih.gov/pubmed/31281723
http://dx.doi.org/10.4048/jbc.2019.22.e23

Ejemplares similares